Heart failure with supra-normal left ventricular ejection fraction: distinct polygenic bases of an unrecognized phenotype

Affiliations

Free article

Editorial

Gianfranco Sinagra et al. Eur J Heart Fail. 2022 Nov.

Free article

. 2022 Nov;24(11):2128-2130.

doi: 10.1002/ejhf.2657. Epub 2022 Sep 7.

¹ Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.

No abstract available

Comment on

Genetic and phenotypic profiling of supranormal ejection fraction reveals decreased survival and underdiagnosed heart failure.
Forrest IS, Rocheleau G, Bafna S, Argulian E, Narula J, Natarajan P, Do R. Forrest IS, et al. Eur J Heart Fail. 2022 Nov;24(11):2118-2127. doi: 10.1002/ejhf.2482. Epub 2022 Mar 27. Eur J Heart Fail. 2022. PMID: 35278270 Free PMC article.

1. Wehner GJ, Jing L, Haggerty CM, Suever JD, Leader JB, Hartzel DN, et al. Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie? Eur Heart J. 2020;41:1249-57.
1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022;24:4-131.
1. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:E895-1032.
1. Shah S, Segar MW, Kondamudi N, Ayers C, Chandra A, Matulevicius S, et al. Supranormal left ventricular ejection fraction, stroke volume, and cardiovascular risk: findings from population-based cohort studies. JACC Heart Fail. 2022;10:583-94.
1. Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, et al.; EMPEROR-Preserved Trial Investigators. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385:1451-61.